Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Mulling Core Criteria For Patient-Reported Outcomes

Nov 02 2018

• By Derrick Gingery

Render illustration of Clinical Trial title on medical documents

Related Content

There's More To Patient Experience Data Submissions Than Just Guidances, Advocates Tell US FDA

Mar 21 2018

Patient-Reported Outcomes For Organ Transplant Drugs Could Learn From Other Fields

Oct 04 2018

Drug/Software Combo Platform Coming Soon To US FDA, Gottlieb Says

Oct 24 2018

Patient-Focused Drug Development: US FDA 'Needs To Be Brave,' Tell Sponsors What Works Best

Oct 29 2018

Duchenne Group's Presentation Is Milestone For Patient Involvement

May 02 2016

From Listening To Advising: The Maturation Of US FDA's Patient-Focused Drug Development Program

Jan 09 2018

US FDA’s Patient Input Guidance Opens Door Wider To Social Media Data Collection

Jun 19 2018

Related Companies

Sarepta Therapeutics, Inc.

Additional Topics

United States Clinical Trials FDA Regulation BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window